Dr. Devitt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1240 Lee St
Charlottesville, VA 22908Phone+1 434-924-9333Fax+1 434-244-7526
Education & Training
University of Virginia Medical CenterFellowship, Hematology and Medical Oncology, 2015 - 2018- University of Virginia Medical CenterResidency, Internal Medicine, 2014 - 2015
Indiana University School of MedicineClass of 2011
Certifications & Licensure
VA State Medical License 2011 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 39 citationsA New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors.Ali Raza Khaki, Ang Li, Leonidas Nikolaos Diamantopoulos, Natalie J. Miller, Lucia Carril-Ajuria
European Urology Oncology. 2021-06-01 - 7 citationsEphrinB2 Inhibition and Pembrolizumab in Metastatic Urothelial Carcinoma.Sarmad Sadeghi, David Quinn, Tanya Dorff, Sumanta Pal, Susan Groshen
Journal of Clinical Oncology. 2023-01-20 - 7 citationsAssociation of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma.Rafee Talukder, Dimitrios Makrakis, Genevieve Ihsiu Lin, Leonidas N Diamantopoulos, Scott Dawsey
Clinical Genitourinary Cancer. 2022-12-01
Press Mentions
New Tools Guide Lifestyle Medicine Integration for FPsJune 3rd, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
